Update under Regulation 30 read with Para A Part A of Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
MEDPLUS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Optival Health Solutions Private Limited, a subsidiary of Medplus Health Services, received a one-day suspension order for a drug license of its store located at Gopal Nagar, New Delhi. The order was issued by the Assistant Director, Drugs Control Administration, Delhi, under Rule 65 of the Drugs and Cosmetics Act, 1940 and Rules, 1945. The suspension was received on May 10, 2026. The company estimates a potential revenue loss of Rs 0.30 lakh (approximately Rs 30,000) due to this suspension. Only one store is affected and the impact is limited to a single day of operations.
The financial impact is minimal at Rs 0.30 lakh, and only one store is affected for one day. However, it highlights regulatory compliance risk for the pharmacy retail business. This is a routine regulatory action and unlikely to materially affect the stock price.